Preview Mode Links will not work in preview mode

Aug 24, 2023

Conversation around specific cardiovascular risks, while distinguishing between glycemic control and cardiovascular risk reduction. We will also highlight the benefits of treatment with GLP-1 RA in patients with diabetes.

Claim CE and MOC Credit at 

Aug 15, 2023

This activity focuses on the American Heart Association’s Essential 8 and glucose control. You will learn how GLP-1 RAs accelerate these glucose control goals and contribute to cardiorenal outcomes including how they work.

Claim CE and MOC Credit at